NCT01355653
Completed
Not Applicable
AN OPEN LABEL STUDY TO COMPARE THE EFFECTS OF AGE AND BODY FAT ON THE SAFETY OF TWO HEAT WRAP DEVICES IN HEALTHY SUBJECTS
ConditionsBack Pain
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Back Pain
- Sponsor
- Pfizer
- Enrollment
- 45
- Locations
- 1
- Primary Endpoint
- Percentage of subjects with any thermal-related skin events (defined as elevated skin response, erythema ≥ 2.0 [moderate], or pain upon touch plus non-zero erythema)
- Status
- Completed
- Last Updated
- 10 months ago
Overview
Brief Summary
This study is designed to compare the safety, as measured by skin findings and adverse events, of two different heat devices in elderly, overweight, and elderly and overweight subjects.
Detailed Description
Safety measurements
Investigators
Eligibility Criteria
Inclusion Criteria
- •Males or females in generally good health, and who are either 18-54 years of age with a body mass index of ≥ 30 kg/m2
- •or 55-84 years of age and with a body mass index ≥ 30 kg/m2 or \< 30 kg/m2
- •Females who are not pregnant or breastfeeding
- •Subject is medically cleared for study participation
Exclusion Criteria
- •No sensitivitiy or allergy to device components in contact with skin
- •Any active skin disease or tattoos at the test site that would affect participation
Outcomes
Primary Outcomes
Percentage of subjects with any thermal-related skin events (defined as elevated skin response, erythema ≥ 2.0 [moderate], or pain upon touch plus non-zero erythema)
Time Frame: morning after product wear through 15 days after last product application
Secondary Outcomes
- Percentage of subjects with any adverse event(during and after wear for 28 days after last wear)
Study Sites (1)
Loading locations...
Similar Trials
Completed
Phase 4
SSAT064: Pharmacokinetics of Abacavir/Lamivudine/Dolutegravir in HIV Patients of 60 Years and OverHIVNCT02509195St Stephens Aids Trust40
Completed
Phase 1
Study to Evaluate the Effects of Age & Gender on PK, Safety & Tolerability of HCV-796 Administered to Healthy SubjectsHealthyNCT00407173Wyeth is now a wholly owned subsidiary of Pfizer48
Completed
Phase 1
Single Dose Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Evaluation of Eplivanserin in Children With InsomniaSleep Initiation and Maintenance DisordersNCT00913614Sanofi41
Completed
Phase 4
A Study to Evaluate Satisfaction in Adult Participants With the Aesthetics of the Periorbital Area After JUVÉDERM® Fillers and BOTOX®/VISTABEL® InjectionsFacial CorrectionsFacial LinesNCT05647551AbbVie73
Completed
Phase 1
Study to Assess Effects of Age, Weight, and Body Composition on the Pharmacokinetics of IV Diclofenac SodiumHealthyNCT00509743Javelin Pharmaceuticals89